Why the study?
Does pioglitazone improve carotid intima-media thickness and pulsatility index in type 2 diabetic patients?
Does pioglitazone improve carotid intima-media thickness and pulsatility index in type 2 diabetic patients?
Pioglitazone improves cerebrovascular blood flow (measured by pulsatility index) and metabolic parameters in patients with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Supports cerebrovascular flow and metabolic benefits in T2DM but should not yet change practice; leaves open IMT effects pending RCTs.
Park et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: